阿利吉仑的临床应用
作者：何元军;
Author：
收稿日期： 年卷（期）页码：2008,(02):-244-245
期刊名称：华西药学杂志
Journal Name：WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字：非肽类肾素抑制剂;阿利吉仑;临床应用
Key words：
基金项目：
中文摘要
综述了新型非肽类肾素抑制剂阿利吉仑的药理学特性及临床应用的进展。
参考文献
[1]Wood J,Maibaum J,Rahuel j,et al.Structure based design ofaliskiren,a novel orally effective renin inhibitor[J].Bio BiophysRes Commu,2003,308(4):698-705.
[2]Nussberger J,Wuerzner G,Jensen C,et al.Angiotensin II sup-pression in humans by the orally active renin inhibitor aliskiren:comparison with enalapril[J].Hypert,2002,4(4):269-270.
[3]SICA DA.Combination angiotensin-converting enzyme inhibitorand angiotensinreceptor blocker therapy:its role in clinical prac-tice[J].J Clin Hypertens,2003,5(6):414-420.
[4]Dieterle W,Corynen S,Mann J.Effect of the oral inhibitoraliskiren on the pharmacokineties and pharmacodynanaics of asingle dose ofwarfarin in healthy subjects[J].J Clin Pharma,2004,58(4):433-436.
[5]Stanton A.Therapeutic potential of rennin inhibitors in the ma-negement of cardiovascular disorders[J].Am Cardiovasc Drags,2003,3(6):389-394.
[6]Stanton A,Jensen C,Nussberger J,et al.Blood pressure loweringinessential hypertension with all oral renin inhibitor,Aliskiren[J],Hypertension,2003,42(6):1137-1143.
[7]Nussberger J,Wuerzner G,Jensen C,et al.Angiotensin II sup-pres—sion in humans by the orally active renin inhibitoraliskiren(SPPIO0):comparison with enalapril[J].Hypert,2002,4(4):269-270.
[8]Eoin O’Brien,John Barton.Aliskiren reduces blood pressure andsuppresses plasma renin activity in combination with a thiazide di-uretic,an angiotensin-converting enzyme inhibitor or an angio-tensin receptor blocker[J].Hypert,2007,49:276-284.
[9]Alberto V,Steven G Chrysant,et al.Renin inhibition withaliskiren provides additive antihypertensive efficacy when used incombinationwith hydrochlorothiazide[J].Hypert,2007,25:217-226.
【关闭】
